期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Performance and Stability of Supercapacitor Modules based on Porous Carbon Electrodes in Hybrid Powertrain
1
作者 龚旋 谢长君 +3 位作者 zou yaohui QUAN Shuhai PIOTR Bujlo SHEN Di 《Journal of Wuhan University of Technology(Materials Science)》 SCIE EI CAS 2014年第6期1141-1146,共6页
Hybrid power sources have attracted much attention in the electric vehicle area. Particularly, electric-electric hybrid powertrain system consisting of supercapacitor modules and lithium-ion batteries has been widely ... Hybrid power sources have attracted much attention in the electric vehicle area. Particularly, electric-electric hybrid powertrain system consisting of supercapacitor modules and lithium-ion batteries has been widely applied because of the high power density of supercapacitors. In this study, we design a hybrid powertrain system containing two porous carbon electrode-based supercapacitor modules in parallel and one lithium ion battery pack. With the construction of the testing station, the performance and stability of the used supercapacitor modules are investigated in correlation with the structure of the supercapacitor and the nature of the electrode materials applied. It has been shown that the responding time for voltage vibration from 20 V to 48.5 V during charging or discharging process decreases from about 490 s to 94 s with the increase in applied current from 20 A to 100 A. The capacitance of the capacitor modules is nearly independent on the applied current. With the designed setup, the energy efficiency can reach as high as 0.99. The results described here provide a guidance for material selection of supercapacitors and optimized controlling strategy for hybrid power system applied in electric vehicles. 展开更多
关键词 supercapacitor modules electric-electric hybrid powertrain charging-discharging cycle stability power density
原文传递
健脾益肾通络胶囊联合坎地沙坦酯治疗糖尿病肾病临床研究 被引量:12
2
作者 吴素琴 邹耀辉 吴福建 《国际中医中药杂志》 2020年第6期539-542,共4页
目的评价健脾益肾通络胶囊联合坎地沙坦酯治疗DN的疗效。方法将2015年1月-2018年12月本院符合入选标准的82例患者,采用随机数字表法分为2组,每组41例。对照组口服坎地沙坦酯,研究组在对照组基础上加用健脾益肾通络胶囊。2组均治疗1个月... 目的评价健脾益肾通络胶囊联合坎地沙坦酯治疗DN的疗效。方法将2015年1月-2018年12月本院符合入选标准的82例患者,采用随机数字表法分为2组,每组41例。对照组口服坎地沙坦酯,研究组在对照组基础上加用健脾益肾通络胶囊。2组均治疗1个月。采用全自动生化分析仪检测24 h尿蛋白定量、SCr及BUN,采用ELISA法检测血清内脂素、HbAlc、IL-6、TNF-α水平;观察治疗期间的不良反应,评价临床疗效。结果研究组总有效率为97.6%(40/41)、对照组为85.4%(35/41),2组比较差异有统计学意义(χ^2=3.905,P=0.048)。治疗后,研究组尿液中24 h尿蛋白定量[(64.35±6.39)mg比(96.32±8.74)mg,t=18.908]、SCr[(86.84±9.30)μmol/L比(124.34±13.11)μmol/L,t=14.939]、BUN[(5.41±0.59)mmol/L比(7.58±0.71)mmol/L,t=15.052]水平低于对照组(P<0.01);血清内脂素、HbAlc水平低于对照组(t值分别为10.595、13.140,P值均<0.01);血清IL-6、TNF-α水平均低于对照组(t值分别为10.071、6.969,P值均<0.01)。治疗期间,对照组不良反应发生率为12.2%(5/41)、研究组为4.9%(2/41),2组比较差异无统计学意义(χ^2=1.406,P=0.236)。结论健脾益肾通络胶囊联合坎地沙坦酯可有效改善DN患者的肾功能,减轻炎症反应,提高临床疗效。 展开更多
关键词 糖尿病肾病 健脾益肾通络胶囊 坎地沙坦酯 治疗 临床研究性
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部